Healthcare provider profile · identity verified

Anu B Swarup, M.D.

Internal Medicine · MISSION, TX · NPI 1588622021

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	543	152
Atorvastatin Calcium	Atorvastatin Calcium	511	149
Lisinopril	Lisinopril	359	107
Amlodipine Besylate	Amlodipine Besylate	348	105
Metformin Hcl	Metformin Hcl	315	96
Losartan Potassium	Losartan Potassium	297	89
Omeprazole	Omeprazole	283	86
Simvastatin	Simvastatin	271	88
Gabapentin	Gabapentin	252	80
Metoprolol Succinate	Metoprolol Succinate	235	75
Alendronate Sodium	Alendronate Sodium	220	66
Pravastatin Sodium	Pravastatin Sodium	190	66
Jardiance	Empagliflozin	157	32
Rosuvastatin Calcium	Rosuvastatin Calcium	146	49
Glipizide Er	Glipizide	136	32
Farxiga	Dapagliflozin Propanediol	135	31
Escitalopram Oxalate	Escitalopram Oxalate	121	36
Glipizide	Glipizide	117	40
Tamsulosin Hcl	Tamsulosin Hcl	117	43
Montelukast Sodium	Montelukast Sodium	114	31
Fluticasone Propionate	Fluticasone Propionate	113	42
Sertraline Hcl	Sertraline Hcl	111	25
Pantoprazole Sodium	Pantoprazole Sodium	110	37
Metoprolol Tartrate	Metoprolol Tartrate	107	36
Hydrochlorothiazide	Hydrochlorothiazide	105	33
Ozempic	Semaglutide	99	16
Ibandronate Sodium	Ibandronate Sodium	98	38
Famotidine	Famotidine	97	42
Diclofenac Sodium	Diclofenac Sodium	96	31
Furosemide	Furosemide	96	37
Donepezil Hcl	Donepezil Hcl	95	42
Meloxicam	Meloxicam	95	26
Olmesartan Medoxomil	Olmesartan Medoxomil	88	28
Triamcinolone Acetonide	Triamcinolone Acetonide	84	35
Carvedilol	Carvedilol	81	18
Trazodone Hcl	Trazodone Hcl	80	21
Clopidogrel	Clopidogrel Bisulfate	78	24
Duloxetine Hcl	Duloxetine Hcl	72	21
Tramadol Hcl	Tramadol Hcl	72	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	16
Atenolol	Atenolol	63	14
Esomeprazole Magnesium	Esomeprazole Magnesium	63	17
Oxybutynin Chloride Er	Oxybutynin Chloride	63	20
Ezetimibe	Ezetimibe	60	23
Alprazolam	Alprazolam	58	29
Eliquis	Apixaban	58	17
Lovastatin	Lovastatin	55	16
Januvia	Sitagliptin Phosphate	54	15
Myrbetriq	Mirabegron	54	13
Citalopram Hbr	Citalopram Hydrobromide	53	15
Dicyclomine Hcl	Dicyclomine Hcl	53	15
Meclizine Hcl	Meclizine Hcl	53	19
Albuterol Sulfate Hfa	Albuterol Sulfate	51	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	14
Tresiba Flextouch U-100	Insulin Degludec	49	11
Clonidine Hcl	Clonidine Hcl	46	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	45	12
Enalapril Maleate	Enalapril Maleate	44	suppressed
Paroxetine Hcl	Paroxetine Hcl	44	11
Trulicity	Dulaglutide	44	suppressed
Azithromycin	Azithromycin	43	38
Pregabalin	Pregabalin	43	21
Solifenacin Succinate	Solifenacin Succinate	42	12
Celecoxib	Celecoxib	40	12
Potassium Chloride	Potassium Chloride	40	14
Xarelto	Rivaroxaban	40	suppressed
Mounjaro	Tirzepatide	39	11
Linzess	Linaclotide	38	suppressed
Memantine Hcl	Memantine Hcl	38	16
Baclofen	Baclofen	36	19
Glimepiride	Glimepiride	36	13
Kerendia	Finerenone	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	14
Dutasteride	Dutasteride	35	suppressed
Metformin Hcl Er	Metformin Hcl	35	suppressed
Prednisone	Prednisone	35	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	14
Tresiba Flextouch U-200	Insulin Degludec	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Spironolactone	Spironolactone	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	11
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Ibuprofen	Ibuprofen	26	14
Lorazepam	Lorazepam	25	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Prolia	Denosumab	24	18
Tradjenta	Linagliptin	24	suppressed
Primidone	Primidone	23	suppressed
Vascepa	Icosapent Ethyl	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	11
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Nifedipine Er	Nifedipine	22	11
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Levemir	Insulin Detemir	21	suppressed
Levemir Flexpen	Insulin Detemir	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	12
Entresto	Sacubitril/Valsartan	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Dapagliflozin	Dapagliflozin Propanediol	19	13
Finasteride	Finasteride	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	15
Valsartan	Valsartan	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Constulose	Lactulose	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	18	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Humalog	Insulin Lispro	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Synthroid	Levothyroxine Sodium	16	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	16	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ramipril	Ramipril	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Nadolol	Nadolol	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Topiramate	Topiramate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Desloratadine	Desloratadine	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error